(Q33330710)

25 July 2017

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer (English)

1 reference

25 July 2017

1 reference

O P Isokangas

1

1 reference

25 July 2017

A Knuuttila

2

1 reference

25 July 2017

M Halme

3

1 reference

25 July 2017

M Mäntylä

4

1 reference

25 July 2017

I Lindström

5

1 reference

25 July 2017

V Nikkanen

6

1 reference

25 July 2017

M Viren

7

1 reference

25 July 2017

H Joensuu

8

1 reference

25 July 2017

K Mattson

9

1 reference

25 July 2017

1 September 1999

1 reference

25 July 2017

1 reference

25 July 2017

10

1 reference

25 July 2017

1059-1063

1 reference

25 July 2017

9

1 reference

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

25 July 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Vinorelbine: an overview

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Quality of life during chemotherapy in non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008305017829

7 January 2021

Identifiers

DOI

10.1023/A:1008305017829

1 reference

25 July 2017

1 reference